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EpigeneticsOur unique collection of memories determines our individuality and shapes our future interactions with
the world. Remarkable advances into the neurobiological basis of memory have identiﬁed key epigenetic
mechanisms that support the stability of memory. Various forms of epigenetic regulation at the levels of
DNAmethylation, histonemodiﬁcation, andnoncodingRNAs canmodulate transcriptional and translation-
al events required for memory processes. By changing the cellular proﬁle in the brain’s emotional, reward,
and memory circuits, these epigenetic modiﬁcations have also been linked to perseverant, pathogenic
memories. In this review, wewill delve into the relevance of epigenetic dysregulation to pathogenic mem-
ory mechanisms by focusing on 2 neuropsychiatric disorders perpetuated by aberrant memory associa-
tions: substance use disorder and post-traumatic stress disorder. As our understanding improves,
neuroepigenetic mechanisms may someday be harnessed to develop novel therapeutic targets for the
treatment of these chronic, relapsing disorders.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Memory formation requires the complex reﬁnement of synaptic
structures to yield long-lasting changes in plasticity that support
and maintain a memory trace. Nuclear histone modiﬁcations are
poised to regulate such processes because they receive cellular sig-
nals and integrate this molecular information into transcriptional
and translational events that modulate synaptic plasticity. Rodent
learning andmemoryparadigms result in hyperacetylation of histone
proteins in an ERK/MAPK-dependentmanner, illustrating this princi-
ple of signal integration and demonstrating that histone acetylation is
a hallmark feature of memory formation (Levenson et al., 2004;
Swank & Sweatt, 2001). Dampening histone acetylation by decreas-
ing histone acetyltransferases or overexpressing histone deacetylases
(HDACs) produces deﬁcits in contextual fear learning, synaptic plas-
ticity, dendritic synapse structure, and long-term memory (Alarcon
et al., 2004; Guan et al., 2009; Korzus et al., 2004; Oliveira et al.,
2007; Wood et al., 2006). Conversely, HDAC inhibitors promote his-
tone acetylation and have been hypothesized to change the synaptic
architecture of dendrites, allowing for new synapses to take shape
during memory formation (Fischer et al., 2007), thus ameliorating
impairments of neuronal plasticity and memory, boosting cognitive
function, and increasing synapse number (Alarcon et al., 2004;
Guan et al., 2009; Kilgore et al., 2010; Korzus et al., 2004; Levenson
et al., 2004; Ricobaraza et al., 2009; Stefanko et al., 2009; Vecsey
et al., 2007).. This is an open access article unInterestingly, pretreatment with an HDAC inhibitor can counter-
act and overcome the memory-disrupting effects of DNA methyl-
transferase (DNMT) inhibition, indicating that multiple epigenetic
signals are integrated to produce a behavioral outcome (Miller
et al., 2008). Epigenetic regulation by methylation of genomic DNA
contributes to the support of stable memory consolidation, as well
as dynamic synaptic processes during newmemory formation, dem-
onstrating its utility as a reversible post-translational modiﬁcation
(Kangaspeska et al., 2008; Metivier et al., 2008; Miller & Sweatt,
2007). Indeed, DNA methylation is a critical contributor to memory
consolidation and learning-induced synaptic plasticity, events that
can be blocked by DNMT inhibition (Levenson et al., 2006; Miller
et al., 2008). At the transcriptional level, alteration of DNA methyla-
tion within the hippocampus at the time of learning has bidirectional
consequences on gene expression, inducing genes that supportmem-
ory formation while silencing memory-suppressing genes (Lubin
et al., 2008;Miller & Sweatt, 2007). Interestingly, hippocampalmeth-
ylation induced by learning at gene promoters that have been
assayed appears to be transient, returning to baseline within
24 hours (Miller & Sweatt, 2007). However, cortical integration oc-
curs during consolidation of memories, shifting a hippocampus-
dependent memory to rely on the cortex and, ultimately, resulting
in a lasting cortical hypermethylation pattern in the cortex that con-
tributes to preservation of the memory trace (Miller et al., 2010).
Thus, integrative DNAmethylation represents both dynamic and sta-
ble processes ofmemory formation. For additional information on the
general mechanisms discussed above, a number of more extensive,
excellent reviews have been written on histone modiﬁcations andder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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2013; Roth & Sweatt, 2009; Zovkic et al., 2013a).
Beyond these traditional modiﬁcations, noncoding RNAs have
emerged as potent epigenetic regulators that can ubiquitously repress
and/or activate a broad repertoire of targets.MicroRNAs (miRNAs) are
noncoding, endogenous RNAs that act as translational repressors
through direct binding to the 3’-UTR of target mRNAs and
noncleavage degradation of the target mRNA via deadenylation
(Djuranovic et al., 2012; Eulalio et al., 2009; Lim et al., 2005). Because
a single miRNA has hundreds of predicted targets based on seed re-
gion complementarity, this wide genomic range likely affords it the
ability to efﬁciently coordinate complex processes, such as those re-
quired to form and maintain a memory (Griggs et al., 2013). Indeed,
miRNAs have been studied for their involvement in basicmechanisms
of learning andmemory, synaptic plasticity, and cognitive dysfunction
(for review, see Saab&Mansuy, 2014). For example, the brain-speciﬁc
miR-134 is enriched in the synaptodendritic compartment of cultured
hippocampal neurons, where it targets actin-related proteins that reg-
ulate spine development (Schratt et al., 2006). Because actin is the
major cytoskeletal component of dendritic spines (Pontrello & Ethell,
2009) and its polymerization is required for the regulation of structur-
al and functional plasticity and memory formation (Fischer et al.,
2004; Gavin et al., 2012; Mantzur et al., 2009; Rehberg et al., 2010;
Rex et al., 2010), miRNAs like miR-134 are well suited to exert strict
regulatory control over structural plasticity (Edbauer et al., 2010;
Fiore et al., 2009; Siegel et al., 2009; Yu et al., 2008). Indeed, exposure
to conditioned fear learning paradigms regulates the expression of
several miRNAs (Griggs et al., 2013; Lin et al., 2011; Wang et al.,
2013), andmanipulation of a single miRNA can prevent memory con-
solidation and inhibit learning-induced dendritic spine changes (Gao
et al., 2010; Griggs et al., 2013; Hansen et al., 2010; Lin et al., 2011;
Scott et al., 2012; Wang et al., 2013).
Although recent work in the ﬁeld of neuroepigenetics has provided
us with insight into the effects of epigenetic dysregulation during
memory processes, we have only reached the tip of the iceberg. It is
well established that stressful, pathogenic events such as abuse,
early-life trauma, and combat exposure induce epigenetic modiﬁca-
tions (Labonte et al., 2012a, 2014; McGowan et al., 2009; Suderman
et al., 2012; Yehuda et al., 2014) that have been linked to neuropsychi-
atric disease susceptibility (Labonte et al., 2012b; Russo et al., 2012).
However, much remains elusive regarding the role of epigenetics in
maintaining long-lasting pathogenic memories such as those experi-
enced by substance abusers and post-traumatic stress disorder
(PTSD) patients. Moreover, a better grasp of the ability of epigenetic
mechanisms tomodulate pathogenicmemorieswill allow for the iden-
tiﬁcation of potential targets for therapeutic use in the treatment of
deeply engrained associations capable of perpetuating substance use
disorder (SUD) and PTSD.
Epigenetic mechanisms in pathogenic memory:
drug-associated memories
Learned associations between environmental stimuli and the
rewarding effects of drugs of abuse serve as lasting, potent memories
capable of triggering a conditioned, physiological response and feel-
ings of intense craving in abstinent drug users. These memories are
highly resistant to extinction and contribute to the high rate of re-
lapse among addicts. Therefore, a common approach in the ﬁeld is
to identify mechanisms capable of accelerating the extinction or
blocking the reconsolidation of these deeply engrained memories.
Our understanding of epigenetic contributions to these memories is
limited, and far more is known about the mechanisms contributing
to the formation of drug-associated memories than the mechanisms
involved in their expression, extinction, or reconsolidation.Currently, everything known about epigenetic contributions to drug-
associatedmemories comes fromstudies using conditionedplaceprefer-
ence (CPP), a behavior task in which animals learn to associate the re-
warding effects of a drug with the environmental context in which it is
administered and later show a preference for that environment. Histone
acetylation and methylation, as well as DNA methylation, have been
implicated in the formation and extinction of drug-context associations.
For instance, elevating histone acetylation via HDAC inhibition (HDACi)
enhances cocaine,morphine, and heroin place preferences but decreases
nicotine CPP (Hui et al., 2010; Kumar et al., 2005; Pastor et al., 2011;
Raybuck et al., 2013; Sanchis-Segura et al., 2009; Schroeder et al., 2008;
Sheng et al., 2011). Similarly, HDACi accelerates the extinction of cocaine
and morphine CPP (Malvaez et al., 2010; Raybuck et al., 2013; Wang
et al., 2010) and prevents the blockade of morphine CPP reconsolidation
inducedby an inhibitor of nuclear factor-kB (Yang et al., 2011).However,
HDACi was shown in another study to delay cocaine CPP extinction
(Itzhak et al., 2013). Under certain conditions, rodents develop condi-
tioned place aversions to ethanol andmorphine, and rather than the ac-
celerated extinction seen with place preferences, HDACi seems to delay
the extinction of these aversive memories (Pascual et al., 2012; Wang
et al., 2012).
Because there are 11 HDAC isoforms, excluding the non–histone-
related sirtuins, that can be subdivided into 4 classes, a major goal
within theﬁeld of neuroepigenetics is to identifywhichHDACs contrib-
ute to the behavioral effects identiﬁed with somewhat broadly acting
HDAC inhibitors. To that end, overexpression of HDAC4 in the striatum
has been found to disrupt a cocaine place preference (Kumar et al.,
2005). This same type of association is enhanced by genetic knock-
down of HDAC3 within the brain’s reward center, the nucleus accum-
bens (NAc) (Rogge et al., 2013). Furthermore, reducing the nuclear
accumulation of HDAC5 in the NAc via dephosphorylation and focal
knockdown of the histone acetyltransferase CBP in the NAc both dis-
rupt cocaine CPP (Malvaez et al., 2011; Taniguchi et al., 2012). New
HDAC inhibitors are becoming available with increased selectivity,
and one such compound, RGFP966, bears a high degree of speciﬁcity
for HDAC3, a member of the class I family of HDACs. Consistent with
the effect of more broadly acting HDACis, inhibition limited to HDAC3
was also capable of enhancing cocaine CPP (Malvaez et al., 2013).
By adding methyl groups to lysine 9 on histone H3 (H3K9), the
histone methyltransferase G9a is capable of inhibiting transcription.
Consistent with this function, intra-NAc knockdown of G9a enhanced
cocaineCPP,whereas overexpression disrupted a place preference for
morphine CPP (Maze et al., 2010; Sun et al., 2012). Recent technical
advances are allowing researchers to target subpopulations of neu-
rons. This is particularly advantageous in the striatum, a brain region
populated by neurons with very different downstream projections.
These neurons can be delineated by their expression of either the
D1 receptor or D2 receptor. A recent study employing one such cell
type–speciﬁc technique found that G9a knockdown in D1-
containing striatal neurons decreased cocaine CPP, whereas knock-
down in D2 neurons enhanced the strength of the association
(Maze et al., 2014). Similarly, knockdownof the transcriptionally per-
missive H3K4 histone methyltransferase Mll1 in the NAc
prevented the formation of a methamphetamine place preference
(Aguilar-Valles et al., 2013). H3K4 methyl moieties can be removed
by the histone demethylase Kdm5c driving transcriptional repression.
Interestingly, intra-NAc knockdown of this enzyme has no effect on
the formation of a methamphetamine association but prevents its
storage and/or expression (Aguilar-Valles et al., 2013).
DNAmethylation and noncodingRNAs have received even less at-
tention in the context of drug-associated memory. DNA methylation
is associatedwith transcriptional silencing and represents another at-
tractive mechanism for mediating long-lasting memories (Miller &
Sweatt, 2007; Miller et al., 2010). Changes in DNA methylation can
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Dnmt3a and Dnmt3b. Indeed, reduction of the repressive state has
been observed in the brain’s reward system after a single administra-
tion of cocaine through changes in Dnmt3a expression, and chronic,
systemic methyl supplementation with methionine disrupted a
place preference for cocaine (LaPlant et al., 2010; Tian et al., 2012).
Paradoxically, infusion of a DNMT inhibitor directly into area CA1 of
the hippocampus also disrupted the formation of cocaine CPP (Han
et al., 2010), whereas DNMT inhibition in the NAc enhanced cocaine
CPP (LaPlant et al., 2010). In additional, the expression of cocaine CPP
was prevented by DNMT inhibition within the prelimbic cortex (Han
et al., 2010). Together, these results indicate a clear need to identify
the gene- and region-speciﬁc roles of DNA methylation, as well as
this epigenetic modiﬁcation’s contribution to the long-term storage
of drug-associated memories.
Noncoding RNAs have been implicated in transcriptional and
translational regulation. Recent studies suggest that cocaine and
heroin can induce changes in long, noncoding RNA (lncRNA) expres-
sion (Bu et al., 2012; Michelhaugh et al., 2011). For example, the ex-
pression proﬁles of lncRNAs and associatedmRNA are changed in the
NAc 24 hours after expression of cocaine CPP (Bu et al., 2012).
MicroRNAs are also changed after cocaine locomotor sensitization, a
process involving substantial synaptic plasticity (Eipper-Mains
et al., 2011). Speciﬁc miRNAs have also been implicated in the regu-
lation of the transcription factor CREB as well as BDNF (Hollander
et al., 2010; Im et al., 2010), both ofwhich are key participants in syn-
aptic plasticity. Although further investigation will be required to de-
termine if differential proﬁles of lncRNAs and miRNAs occur during
the different phases ofmemory, aswell as identiﬁcation of the under-
lyingmechanisms, the existing data suggest that theymay be capable
of participating in the formation and perhaps postconsolidation reg-
ulation of drug-associated memories.
Together, these ﬁndings suggest that substances of abuse have the
capacity to prime neural circuits to increase susceptibility to relapse
bymediating long-lastingmemories through either facilitating a per-
missive state or inhibiting a repressive state. However, a challenge
presented by CPP acquisition studies involves interpretation of the
ﬁndings, as they are used as both a measure of drug reward and
learning ability. Indeed, most authors have interpreted their acquisi-
tion phase ﬁndings, particularly those related to the NAc, as
epigenetic-induced changes to the rewarding properties of drugs of
abuse. This interpretation is supported by the numerous, concomi-
tant reports of changes in locomotor sensitization with epigenetic
modiﬁcation. The likelihood of inﬂuences on reward, rather than
learning, is further indicated by the ﬁnding that HDAC inhibition
with sodium butyrate increases cocaine self-administration during
the protocol’smaintenance phase (Sun et al., 2008). However, anoth-
er study found that systemic HDAC inhibition with trichostatin A or
phenylbutyrate decreased cocaine self-administration and correlated
with decreased HDAC activity within the prefrontal cortex, a key
member of the neural circuitry governing drug-associated memory
(Romieu et al., 2008). This may represent epigenetic-mediated com-
pensatory actions in the prefrontal cortex, such as activation of BDNF
(Sadri-Vakili et al., 2010). Interestingly, the discrepancy of ﬁndings
between the 2 studies examining the effects of HDAC inhibition on
cocaine self-administration may lie in the selectivity of the particular
inhibitors thatwere used.Whereas trichostatinA and phenylbutyrate
are broad-spectrumHDAC inhibitors, hittingmembers of everyHDAC
Class, sodium butyrate’s targets are limited to class I HDACs (HDAC1,
2, 3, and 8) (Kilgore et al., 2010). Regardless, there is clearly a need to
further characterize the region-speciﬁc contribution of epigenetic
modiﬁers to drug-associated and other pathologic memory associa-
tions, particularly in terms of how these memories are stored,
expressed, and subsequently modiﬁed.Epigenetic mechanisms in pathogenic memory:
implications for PTSD
During PTSD, an individual experiences or witnesses a traumatic
event or events that later lead to substantial dysfunction in fear pro-
cessing, including hyperactivation of the amygdala (AMY), upon ex-
posure to fearful stimuli and generalization of fearful responses to
nonfearful stimuli. The AMY, the brain's emotional memory center,
plays a critical role in many forms of cognition, including psychiatric
disorders with a memory component (Childress et al., 1999; Koenigs
& Grafman, 2009). Unlike hippocampus-dependentmemories, which
shift to the cortex as long-term memory develops (Dudai, 2004;
Frankland et al., 2004;Miller et al., 2010), AMY-dependentmemories
continue to rely on the AMY weeks after learning (Kwon et al., 2012;
Squire & Bayley, 2007). Understanding the mechanisms through
which the AMY maintains these painful memories in a stable state
for months to years has signiﬁcant clinical importance. Given the
powerful transcriptional and translational effects of epigenetic mod-
iﬁcations, aswell as their long-lastingpotential, epigenetics represent
a promising avenue of research for PTSD.
Stress has been shown to induce epigenetic modiﬁcations
(Gudsnuk & Champagne, 2012; Hunter & McEwen, 2013). Taken to-
gether with the fact that manipulation of the chromatin state or
abundance of regulatory miRNAs can affect how the brain forms
and recalls a memory, one can postulate that a stressful event that
precipitates PTSD will produce epigenetic changes in brain regions
that differentially process thatmemory, aswell as the subsequent be-
havioral responses to reminders of the stressful event. In accordance
with this notion, the pathogenic memories of PTSD are resistant to
prolonged exposure therapy (i.e., extinction). Therefore, the focus of
many researchers in the ﬁeld has been to identify molecular targets
that accelerate the extinction process.
Evidence that epigeneticmechanisms contribute to the perseverant
memory state that is characteristic of PTSD is beginning to accumulate
(Yehuda&Bierer, 2009; Zovkic& Sweatt, 2013; Zovkic et al., 2013b). As
mentioned above, traditional fear conditioning in rodents has provided
insight into the epigenetic mechanisms of memory, thus laying the
groundwork for traumatic fear memory studies in models of PTSD
with strong face validity (Cohen et al., 2012; Goswami et al., 2013).
Most studies on pathogenic memory research have used animal
models of PTSD that include a test of “traumatic memory” in a condi-
tioned fear paradigm. For instance, in rodents, a “normal” fearmemory
can be converted to a traumatic, extinction-resistant memory by pre-
exposure to a stressor (Yamamoto et al., 2009). Subsequent fear condi-
tioning results in a fear memory that displays greater resistance to ex-
tinction than one formed in the absence of prior stress (Chauveau et al.,
2012; Yamamoto et al., 2009). Treatmentwith anHDAC inhibitor ame-
liorates fear extinction deﬁcits in such a paradigm, presumably because
it increases histone acetylation to support the formation of new extinc-
tion memories (Matsumoto et al., 2013). Under basal conditions, this
model produces enhanced consolidation after contextual fear condi-
tioning and increased acetylation of histones H3 andH4 at the promot-
er of bdnf (Takei et al., 2011). When taking into consideration the fact
that histone acetylation contributes to basic memory processes, these
studies suggest that histone acetylation contributes to the formation
of a very strong initial fear memory in PTSD but that it can also be
exploited for the formation of extinctionmemories that aid in the inhi-
bition of pathogenic fear memory responses.
Although many studies have reported altered DNA methylation
patterns in PTSD patients or animal models of PTSD (for review, see
Stankiewicz et al., 2013; Klengel et al., 2014), the contribution of
these epigenetic changes to the development or maintenance of
PTSD traumatic memories has not been described. Likewise, the
role of miRNAs in PTSD remains a complete mystery. In recent
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scribed, in which key facets of the disorder, such as fear extinction re-
sistance and generalization of fear, are recapitulated (Cohen et al.,
2012; Goswami et al., 2013). Therefore, it is highly likely that future
studies will employ these models to delve into the roles of epigenetic
modiﬁcations in pathogenic memory processes. Finally, it should be
noted that the development of PTSD is considered a maladaptive re-
sponse to a stressful event. Exposure to stress throughout life is un-
avoidable, yet most individuals are resilient and do not develop
PTSD (Galea et al., 2005; Russo et al., 2012). The interaction between
vulnerable genetic factors and exposure-based epigenetic modiﬁca-
tions that one incurs throughout life is believed to be a crucial con-
tributor to the individual variability seen in the development of
disorders such as PTSD (Zovkic et al., 2013b). Thus, pathogenic epige-
netic modiﬁcations induced by stress in some individuals
may dysregulate the mechanisms recruited for the formation, stor-
age, and/or retrieval of a subsequent, particularly salient, stressful
event. This could also lead to resistance of the “traumatic” memory
to extinction and inappropriately sensitized behavioral responses to
seemingly nonstressful stimuli.
Conclusion
Understanding the contribution of epigeneticmechanisms to how
pathologic memories associated with SUD and PTSD are stored,
expressed, and subsequently modiﬁed will have the potential to un-
cover novel therapeutic targets. However, the current status of the
literature highlights the need to reﬁne themodels inwhich these dis-
orders are investigated. In the context of SUD, CPP studies represent a
ﬁrst-line approach to identifying novel therapeutic targets, but the
next stepwill be to test them in gold-standard reinstatementmodels
of self-administration. Similarly, whereas traditional fear condition-
ing paradigms have laid the groundwork for epigenetic studies into
pathogenic memory, the use of models that aim to include multiple
components of PTSD may uncover more relevant epigenetic targets
that will be critical to mitigate this relapsing disorder. Nonetheless,
it will be interesting to see how the current work with rodent fear
conditioning paradigms maps onto future PTSD studies. By using
the most appropriate tools and animal models of SUD and PTSD, fu-
ture studies will allow us to gain critical insight into the therapeutic
window of targets and biomarkers of pathogenic memory disorders.
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